Health Catalyst (NASDAQ: HCAT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Health Catalyst (NASDAQ: HCAT) through any online brokerage.
The latest price target for Health Catalyst (NASDAQ: HCAT) was reported by Raymond James on Tuesday, August 9, 2022. The analyst firm set a price target for 20.00 expecting HCAT to rise to within 12 months (a possible 71.09% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Health Catalyst (NASDAQ: HCAT) is $11.69 last updated August 9, 2022, 8:00 PM UTC.
There are no upcoming dividends for Health Catalyst.
Health Catalyst’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Health Catalyst.
Health Catalyst is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.